# Study of Adebrelimab With Chemotherapy, Endoscopy and Sequential Chemoradiotherapy In Inoperable Esophageal Cancer

Source: https://onco.cc/trials/nct06599775/  
OnCo record `nct06599775` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Endoscopic resection in Oesophageal squamous cell carcinoma, run by Shanghai Zhongshan Hospital, not yet recruiting.

## Summary

Study of Adebrelimab With Chemotherapy, Endoscopy and Sequential Chemoradiotherapy In Inoperable Esophageal Cancer is a phase 2 interventional study registered as NCT06599775 by Shanghai Zhongshan Hospital, with 42 participants planned, started 2024-10 and due to reach its primary completion in 2026-10. Interventions recorded: Adebrelimab injection, Albumin-Bound Paclitaxel, Carboplatin injection. Conditions recorded: Resectable Esophageal Squamous Cell Carcinoma.

Linked to the technology Endoscopic resection because the registry's title names it ("endoscopic resection") and Oesophageal squamous cell carcinoma among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06599775
- Phase: 2
- Setting: Prospective, Single-arm, Multicenter Exploratory Study of Adebrelimab Combined With Chemotherapy, Endoscopic Resection and Sequential Chemoradiotherapy In the Treatment of Inoperable Clinical Staging T1b-2 Esophageal Squamous Cell Carcinoma
- Sponsor: Shanghai Zhongshan Hospital
- Enrolled: 42

## Sources

- ClinicalTrials.gov NCT06599775: https://clinicaltrials.gov/study/NCT06599775

## Connected records

- cancers: [Oesophageal squamous cell carcinoma](https://onco.cc/cancers/oesophageal-squamous-cell-carcinoma/)
- technologies: [Endoscopic resection (EMR / ESD)](https://onco.cc/technologies/endoscopic-resection/)
- drugs: [Adebrelimab](https://onco.cc/drugs/adebrelimab/), [Carboplatin](https://onco.cc/drugs/carboplatin/), [Paclitaxel / nab-paclitaxel](https://onco.cc/drugs/paclitaxel/)

---
JSON: https://onco.cc/api/v1/entities/nct06599775.json